Influence of dietary phytosterols and phytostanols on diastolic blood pressure and the expression of blood pressure regulatory genes in SHRSP and WKY inbred rats

British Journal of Nutrition

Volumn 102, Issue 1, 2009, Pages 93-101

  Chen, Qixuan ^a   Gruber, Heidi ^a   Swist, Eleonora ^a   Pakenham, Catherine ^a   Ratnayake, Walisundera M N ^a   Scoggan, Kylie A ^a,b  

^a Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Blood pressure; Gene expression; Phytostanols; Phytosterols; Rats

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN I CONVERTING ENZYME 1; ANGIOTENSINOGEN; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; PHYTOSTANOL; PHYTOSTEROL; REGULATOR PROTEIN; RENIN; STEROL DERIVATIVE; THUMP DOMAIN CONTAINING 1 PROTEIN; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT; NOS3 PROTEIN, RAT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY INTAKE; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WISTAR KYOTO RAT; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DIASTOLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HYPERTENSION; KIDNEY; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; RANDOMIZATION; SPONTANEOUSLY HYPERTENSIVE RAT;

RATTUS;

ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 2; DIASTOLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; PHYTOSTEROLS; PHYTOTHERAPY; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 69249208777     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508137904     Document Type: Article

References (50)

1. Katan MB, Grundy SM, Jones P, et al. (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78, 965-978.
2. Law M (2000) Plant sterol and stanol margarines and health. Br Med J 320, 861-864.
3. Jones PJ, MacDougall DE, Ntanios F, et al. (1997) Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 75, 217-227.
4. European Food Safety Authority (2008) Consumption of food and beverages with added plant sterols in the European Union. Available online at http://www.efsa.europa.eu/cs/BlobServer/ Scientific- Document/datex- report-ej133- phytosterols-en.pdf ? ssbinary=true, The Efsa Journal 133, 1-21.
5. Lee MH, Lu K, Hazard S, et al. (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27, 79-83.
6. Salen G, Horak I, Rothkopf M, et al. (1985) Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res 26, 1126-1133.
7. Assmann G, Cullen P, Erbey J, et al. (2006) Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 16, 13-21.
8. Sudhop T, Gottwald BM & von Bergmann K (2002) Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 51, 1519-1521.
9. Glueck CJ, Speirs J, Tracy T, et al. (1991) Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 40, 842-848.
10. Fransen HP, de Jong N, Wolfs M, et al. (2007) Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J Nutr 137, 1301-1306.
11. Clifton PM, Mano M, Duchateau GS, et al. (2008) Dose- response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur J Clin Nutr 62, 968-977.
12. Weingärtner O, Lütjohann D, Ji S, et al. (2008) Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 51, 1553-1561.
13. Scoggan KA, Gruber H & Lariviere K (2003) A missense mutation in the Abcg5 gene causes phytosterolemia in SHR, stroke-prone SHR, and WKY rats. J Lipid Res 44, 911-916.
14. Ratnayake WM, Plouffe L, L'Abbé MR, et al. (2003) Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke. Lipids 38, 1237-1247.
15. Ratnayake WMN, L'Abbé MR, Mueller R, et al. (2000) Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr 130, 1166-1178.
16. Ratnayake WMN, Plouffe L, Hollywood R, et al. (2000) Influence of sources of dietary oils on the life span of stroke-prone spontaneously hypertensive rats. Lipids 35, 409-420.
17. Carswell HV, McBride MW, Graham D, et al. (2005) Mutant animal models of stroke and gene expression: the stroke-prone spontaneously hypertensive rat. Methods Mol Med 104, 49-74.
18. Okamoto K, Yamori Y & Nagaoka A (1974) Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res 34, 143-153.
19. Satoh T, Owada S & Ishida M (1999) Recent aspects in the genetic renal mechanisms involved in hypertension. Intern Med 38, 919-926.
20. American Institute of Nutrition (1993) AIN-93 Purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
21. Scoggan KA, Gruber H, Chen Q, et al (2008) Increased incorporation of dietary plant sterols and cholesterol correlates with decreased expression of hepatic and intestinal Abcg5 and Abcg8 in diabetic BB rats, J Nutr Biochem (Epublication ahead of print version 9 June 2008).
22. Yu H, Pandit B, Klett E, et al. (2003) The rat STSL locus: characterization, chromosomal assignment, and genetic variations in sitosterolemic hypertensive rats. BMC Cardiovasc Disord 3, 4-23.
23. Boustany CM, Bharadwaj K, Daugherty A, et al. (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287, R943-R949.
24. Nakazawa R, Tanaka M, Takahashi T, et al. (2007) Effects of castration and testosterone administration on angiotensin II receptor mRNA expression and apoptosis-related proteins in rat urinary bladder. Endocr J 54, 211-219.
25. Ogawa H, Yamamoto K, Kamisako T, et al. (2003) Phytosterol additives increase blood pressure and promote stroke onset in salt-loaded stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 30, 919-924.
26. Naito Y, Nagata T, Takano Y, et al. (2003) Rapeseed oil ingestion and exacerbation of hypertension-related conditions in stroke prone spontaneously hypertensive rats. Toxicology 187, 205-216.
27. Naito Y, Kasama K, Yoshida H, et al. (2000) Thirteen-week dietary intake of rapeseed oil or soybean oil as the only dietary fat in Wistar Kyoto rats-change in blood pressure. Food Chem Toxicol 38, 811-816.
28. Hammoud RA, Vaccari CS, Nagamia SH, et al. (2007) Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vasc Health Risk Manag 3, 937-945.
29. Obata J, Nakamura T, Takano H, et al. (2000) Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 18, 1247-1255.
30. Takemori K, Ishida H & Ito H (2005) Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats. Life Sci 77, 2233-2245.
31. Schulz E, Jansen T, Wenzel P, et al. (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10, 1115-1126.
32. Arehart E, Gleim S, Kasza Z, et al. (2007) Prostacyclin, atherothrombosis, and cardiovascular disease. Curr Med Chem 14, 2161-2169.
33. Xia Y, Dawson VL, Dawson TM, et al. (1996) Nitric oxide synthase generates superoxide and nitric oxide in argininedepleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 93, 6770-6774.
34. Pryor WA & Squadrito GL (1995) The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268, L699-L722.
35. Zou MH (2007) Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82, 119-127.
36. Bachschmid M, Thurau S, Zou MH, et al. (2003) Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J 17, 914-916.
37. Upmacis RK, Deeb RS & Hajjar DP (2007) Reprint of oxidative alterations of cyclooxygenase during atherogenesis [Prostag Oth. Lipid. M. 80 (2006) 1-14]. Prostaglandlins Other Lipid Mediat 82, I-XIV.
38. Harris RC, Zhang MZ & Cheng HF (2004) Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand 181, 543-547.
39. Cosentino F, Sill JC & Katusić ZS (1994) Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 23, 229-235.
40. McBride MW, Brosnan MJ, Mathers J, et al. (2005) Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 45, 786-792.
41. Kukreja RC, Kontos HA, Hess ML, et al. (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59, 612-619.
42. Kerr S, Brosnan MJ, McIntyre M, et al. (1999) Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33, 1353-1358.
43. Hamilton CA, Miller WH, Al-Benna S, et al. (2004) Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 106, 219-234.
44. Ohara N, Kasama K, Naito Y, et al. (2008) Different effects of 26-week dietary intake of rapeseed oil and soybean oil on plasma lipid levels, glucose-6-phosphate dehydrogenase activity and cyclooxygenase-2 expression in spontaneously hypertensive rats. Food Chem Toxicol 46, 2573-2579.
45. Bermúdez V, Bermúdez F, Acosta G, et al. (2008) Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition. Am J Ther 15, 326-333.
46. Matsui R, Xu S, Maitland KA, et al. (2006) Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(2/2) mice. Arterioscler Thromb Vasc Biol 26, 910-916.
47. Lassègue B & Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285, R277-R297.
48. Van Heerebeek L, Meischl C, Stooker W, et al. (2002) NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 55, 561-568.
49. Clemitson JR, Dixon RJ, Haines S, et al. (2007) Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene. Circ Res 100, 992-999.
50. Hubner N, Wallace CA, Zimdahl H, et al. (2005) Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 37, 243-253.